45
Views
65
CrossRef citations to date
0
Altmetric
Reports

Preparation and production of a cancer chemopreventive agent, Bowman‐Birk inhibitor concentrate

, , &
Pages 281-302 | Received 16 Oct 1992, Accepted 19 Jan 1993, Published online: 04 Aug 2009

References

  • Kennedy , AR . “Overview: Anticarcinogenic Activity of Protease Inhibitors” . In Protease Inhibitors as Cancer Chemopreventive Agents , Edited by: Troll , W and Kennedy , AR . New York : Plenum . In press
  • Kennedy , AR . “ In Vitro Studies of Anticarcinogenic Protease Inhibitors” . In Protease Inhibitors as Cancer Chemopreventive Agents , Edited by: Troll , W and Kennedy , AR . New York : Plenum . In press
  • Troll , W , Frenkel , K and Wiesner , R . 1984 . “Protease Inhibitors as Anticarcinogens” . JNCI , 73 : 1245 – 1250 .
  • Weed , H , McGandy , RB and Kennedy , AR . 1985 . “Protection Against Dimethylhydrazine Induced Adenomatous Tumors of the Mouse Colon by the Dietary Addition of an Extract of Soybeans Containing the Bowman‐Birk Protease Inhibitor” . Carcinogenesis , 6 : 1239 – 1241 .
  • Messadi , PV , Billings , P , Shklar , G and Kennedy , AR . 1986 . “Inhibition of Oral Carcinogenesis by a Protease Inhibitor” . JNCI , 76 : 447 – 452 .
  • Kennedy , AR and Billings , PC . 1987 . “Anticarcinogenic Actions of Protease Inhibitors” . In Anticarcinogenesis and Radiation Protection , Edited by: Cerutti , PA , Nygaard , OF and Simic , MG . 285 – 295 . New York : Plenum .
  • St Clair , W , Billings , P , Carew , J , Keller‐McGandy , C Newberne , P . 1990 . “Suppression of DMH‐Induced Carcinogenesis in Mice by Dietary Addition of the Bowman‐Birk Protease Inhibitor” . Cancer Res , 50 : 580 – 586 .
  • Witschi , H and Kennedy , AR . 1989 . “Modulation of Lung Tumor Development in Mice With the Soybean‐Derived Bowman‐Birk Protease Inhibitor” . Carcinogenesis , 10 : 2275 – 2277 .
  • Billings , PC , Newberne , P and Kennedy , AR . 1990 . “Protease Inhibitor Suppression of Colon and Anal Gland Carcinogenesis Induced by Dimethylhydrazine” . Carcinogenesis , 11 : 1083 – 1086 .
  • Von Hofe , E , Newberne , PM and Kennedy , AR . 1991 . “Inhibition of N‐Nitrosomethylbenzylamine Induced Esophageal Neoplasms by the Bowman‐Birk Protease Inhibitor” . Carcinogenesis , 12 : 2147 – 2150 .
  • Kennedy , AR , Billings , PC , Maki , PA and Newberne , P . 1993 . “Effects of Various Protease Inhibitor Preparations on Oral Carcinogenesis in Hamsters Induced by 7,12‐Dimethylbenz[a]anthracene” . Nutr Cancer , 19 : 191 – 200 .
  • Yavelow , J , Finlay , TH , Kennedy , AR and Troll , W . 1983 . “Bowman‐Birk Soybean Protease Inhibitor as an Anticarcinogen” . Cancer Res , 43 : 2454 – 2459 .
  • Kennedy , AR . 1984 . “Prevention of Radiation‐Induced Transformation In Vitro. “ ” . In Vitamins, Nutrition and Cancer , Edited by: Prasad , KN . 166 – 179 . Basel : Karger .
  • Yavelow , J , Collins , M , Birk , Y , Troll , W and Kennedy , AR . 1985 . “Nanotnolar Concentrations of Bowman‐Birk Soybean Protease Inhibitor Suppress X‐Ray Induced Transformation In Vitro” . Proc Nati Acad Sci USA , 82 : 5395 – 5399 .
  • Kennedy , AR . 1985 . “The Conditions for the Modification of Radiation Transformation In Vitro by a Tumor Promoter and Protease Inhibitors” . Carcinogenesis , 6 : 1441 – 1446 .
  • Baturay , NZ and Kennedy , AR . 1986 . “Pyrene Acts as a Cocarcinogen With the Carcinogens, Benzo[a]pyrene, β‐Propiolactone and Radiation, in the Induction of Malignant Transformation of Cultured Mouse Fibroblasts; Soybean Extract Containing the Bowman‐Birk Inhibitor Acts as an Anticarcinogen” . Cell Biol Toxicol , 2 : 21 – 32 .
  • Kennedy , AR . 1988 . “Implications for Mechanisms of Tumor Promotion and Its Inhibition by Various Agents From Studies of In Vitro Transformation” . In Tumor Promoters, Biological Approaches for Mechanistic Studies and Assay Systems , Edited by: Langenbach , R , Barrett , JC and Elmore , E . 201 – 212 . New York : Raven .
  • Kennedy , AR and Billings , PC . 1987 . “Anticarcinogenic Actions of Protease Inhibitors” . In Anticarcinogenesis and Radiation Protection , Edited by: Cerutti , PA , Nygaard , OF and Simic , MG . 285 – 295 . New York : Plenum .
  • Kennedy , AR . 1990 . “Effects of Protease Inhibitors and Vitamin E in the Prevention of Cancer” . In Nutrients and Cancer Prevention , Edited by: Prasad , KN and Meyskens , FL Jr . 79 – 98 . Clifton, NJ : Humana .
  • St. Clair , WH . 1991 . “Suppression of 3‐Methylcholanthrene‐Induced Cellular Transformation by Timed Administration of the Bowman‐Birk Protease Inhibitor” . Carcinogenesis , 12 : 935 – 937 .
  • Billings , PC , Carew , JA , Keller‐McGandy , CE , Goldberg , A and Kennedy , AR . 1987 . “A Serine Protease Activity in C3H/10T1/2 Cells That Is Inhibited by Anticarcinogenic Protease Inhibitors” . Proc Natl Acad Sci USA , 84 : 4801 – 4805 .
  • Billings , PC , St Clair , W , Owen , AJ and Kennedy , AR . 1988 . “Potential Intracellular Target Proteins of the Anticarcinogenic Bowman‐Birk Protease Inhibitor Identified by Affinity Chromatography” . Cancer Res , 48 : 1798 – 1802 .
  • Carew , JA and Kennedy , AR . 1990 . “Identification of a Proteolytic Activity Which Responds to Anticarcinogenic Protease Inhibitors in C3H10T1/2 Cells” . Cancer Lett , 49 : 153 – 163 .
  • Yavelow , J , Caggana , M and Beck , KA . 1987 . “Proteases Occurring in the Cell Membrane: A Possible Receptor for the Bowman Birk Type of Protease Inhibitors” . Cancer Res , 47 : 1598 – 1601 .
  • Billings , PC , Habres , JM , Liao , DC and Tuttle , SW . 1991 . “A Protease Activity in Human Fibroblasts Which Is Inhibited by the Anticarcinogenic Bowman‐Birk Protease Inhibitor” . Cancer Res , 51 : 5539 – 5543 .
  • Billings , PC and Habres , JM . 1992 . “A Growth Regulated Protease Activity Which Is Inhibited by the Anticarcinogenic Bowman‐Birk Protease Inhibitor” . Proc Natl Acad Sci USA , 89 : 3120 – 3124 .
  • Billings , PC . “Approaches to Studying the Target Enzymes of Anticarcinogenic Protease Inhibitors” . In Protease Inhibitors as Cancer Chemopreventive Agents , Edited by: Troll , W and Kennedy , AR . New York : Plenum . In press
  • Habres , JM and Billings , PC . 1992 . “Intestinal Epithelial Cells Contain a High Molecular Weight Protease Subject to Inhibition by Anticarcinogenic Protease Inhibitors” . Cancer Lett , 63 : 135 – 142 .
  • Oreffo , VIC , Billings , PC , Kennedy , AR and Witschi , H . 1991 . “Acute Effects of the Bowman‐Birk Protease Inhibitor in Mice” . Toxicology , 69 : 165 – 176 .
  • Chang , JD , Billings , P and Kennedy , AR . 1985 . "c‐myc Expression Is Reduced in Antipain‐Treated Proliferating C3H10T1/2 Cells” . Biochem Biophys Res Commun , 133 : 830 – 835 .
  • Chang , JD and Kennedy , AR . 1988 . “Cell Cycle Progression of C3H10T1/2 and 3T3 Cells in the Absence of a Transient Increase in c‐myc RNA Levels” . Carcinogenesis , 9 : 17 – 20 .
  • Caggana , M and Kennedy , AR . 1989 . "c‐fos mRNA Levels Are Reduced in the Presence of Antipain and the Bowman‐Birk Inhibitor” . Carcinogenesis , 10 : 2145 – 2148 .
  • Chang , JD and Kennedy , AR . “Suppression of c‐myc by Anticarcinogenic Protease Inhibitors” . In Protease Inhibitors as Cancer Chemopreventive Agents , Edited by: Troll , W and Kennedy , AR . New York : Plenum . In press
  • Kennedy , AR . 1991 . “Is There a Critical Target Gene for the First Step in Carcinogenesis?” . Environ Health Perspect , 93 : 199 – 203 .
  • St Clair , WH , Billings , PC and Kennedy , AR . 1990 . “The Effects of the Bowman‐Birk Protease Inhibitor on c‐myc Expression and Cell Proliferation in the Unirradiated and Irradiated Mouse Colon” . Cancer Lett , 52 : 145 – 152 .
  • Chang , JD , Li , J‐H , Billings , PC and Kennedy , AR . 1990 . “Effects of Protease Inhibitors on c‐myc Expression in Normal and Transformed C3H10T1/2 Cells” . Mol Carcinog , 3 : 226 – 232 .
  • Garte , SJ , Currie , DC and Troll , W . 1987 . “Inhibition of H‐ras Oncogene Transformation of NIH3T3 Cells by Protease Inhibitors” . Cancer Res , 47 : 3159 – 3162 .
  • Garte , SJ and Troll , W . “Protease Inhibitor Suppression of ras Oncogene Transformation” . In Protease Inhibitors as Cancer Chemopreventive Agents , Edited by: Troll , W and Kennedy , AR . New York : Plenum . In press
  • St Clair , WH and St Clair , DK . 1991 . “Effect of the Bowman‐Birk Protease Inhibitor on the Expression of Oncogenes in the Irradiated Rat Colon” . Cancer Res , 51 : 4539 – 4543 .
  • Frenkel , K , Chrzan , K , Ryan , CA , Wiesner , R and Troll , W . 1987 . “Chymotrypsin‐Specific Protease Inhibitors Decrease H2O2 Formation by Activated Human Polymorphonuclear Leukocytes” . Carcinogenesis , 8 : 1207 – 1212 .
  • Flick , MB and Kennedy , AR . 1991 . “Effect of Protease Inhibitors on DNA Amplification in SV40‐Transformed Chinese Hamster Embryo Cells” . Cancer Lett , 56 : 102 – 108 .
  • Kennedy , AR , Radner , B and Nagasawa , H . 1984 . “Protease Inhibitors Reduce the Frequency of Spontaneous Chromosome Abnormalities in Cells From Patients With Bloom Syndrome” . Proc Natl Acad Sci USA , 81 : 1827 – 1830 .
  • Kassell , B . 1970 . “Trypsin and Chymotrypsin Inhibitors From Soybeans” . Methods Enzymol , 19 : 853 – 862 .
  • Hwang , DLR , Davis‐Lin , KT , Yang , WK and Foard , DT . 1977 . “Purification, Partial Characterization and Immunological Relationships of Multiple Low Molecular Weight Proteinase Inhibitors of Soybean” . Biochim Biophys Acta , 495 : 369 – 382 .
  • Friedman , M and Gumbmann , MR . 1986 . “Nutritional Improvement of Legume Proteins Through Disulfide Interchange” . In Nutritional and Toxicological Significance of Enzyme Inhibitors in Foods , Edited by: Friedman , M . 357 – 389 . New York : Plenum .
  • Kennedy , AR , Fox , M , Murphy , G and Little , JB . 1980 . “Relationship Between X‐Ray Exposure and Malignant Transformation in C3H10T1/2 Cells” . Proc Natl Acad Sci USA , 77 : 7262 – 7266 .
  • Kennedy , AR and Little , JB . 1980 . “Investigation of the Mechanism for the Enhancement of Radiation Transformation In Vitro by TPA” . Carcinogenesis , 1 : 1039 – 1047 .
  • IARC/NCI/EPA Working Group . 1985 . “Cellular and Molecular Mechanisms of Cell Transformation and Standardization of Transformation Assays of Established Cell Lines for the Prediction of Carcinogenic Chemicals— Overview and Recommended Protocols” . Cancer Res , 45 : 2395 – 2399 .
  • Doell , BH , Ebden , CJ and Smith , CA . 1981 . “Trypsin Inhibitor Activity of Conventional Foods Which Are Part of the British Diet and Some Soya Products” . Qual Plant Foods Hum Nutr , 31 : 139 – 150 .
  • 1982 . Nutritional Data for US and Canadian Feeds, , 3rd rev. , Washington, DC : National Academy Press .
  • Rackis , JJ and Anderson , RL . 1964 . “Isolation of Four Soybean Trypsin Inhibitors by DEAE‐Cellulose Chromatography” . Biochem Biophys Res Commun , 15 : 230 – 235 .
  • Sipos , E . 1990 . “Dietary Trends for Vegetable Proteins in Foods” . Inform , 1 : 753 – 757 .
  • Phillips , RL . 1975 . “Role of Life‐Style and Dietary Habits and Risk of Cancer Among Seventh‐Day Adventists” . Cancer Res , 35 : 3513 – 3522 .
  • Mills , PK , Beeson , WL , Abbey , DE , Fraser , GE and Phillips , RL . 1988 . “Dietary Habits and Past Medical History as Related to Fatal Pancreas Cancer Risk Among Adventists” . Cancer , 61 : 2578 – 2585 .
  • Correa , P . 1981 . “Epidemiological Correlations Between Diet and Cancer Frequency” . Cancer Res , 41 : 3685 – 3690 .
  • Birk , Y . 1975 . “Proteinase Inhibitors From Plant Sources” . Methods Enzymol , 45 : 695 – 751 .
  • Armstrong , B and Doll , R . 1975 . “Environmental Factors and Cancer Incidence and Mortality in Different Countries, With Special Reference to Dietary Factors” . Int J Cancer , 15 : 617 – 631 .
  • Doll , R and Peto , R . 1981 . “The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today” . JNCI , 66 : 1193 – 1308 .
  • Von Hofe , E , Brent , R and Kennedy , AR . 1990 . “Inhibition of X‐Ray Induced Exencephaly by Protease Inhibitors” . Radiation Res , 123 : 108 – 111 .
  • Brent , RL . 1978 . “Vulnerability of the Preimplantation Mammalian Embryo” (abstr) . Pediatr Res , 12 : 392
  • Maki , PA and Kennedy , AR . 1992 . “Humoral and Cellular Immune Functions Are Not Compromised by the Anticarcinogenic Bowman‐Birk Inhibitor” . Nutr Cancer , 189 : 165 – 173 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.